AM

Abimanyu Mahendran

Director Director DIN 07828250
DIN 07828250 First appointment Jul 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2017
Shareholding value •••• Premium profile

About Abimanyu Mahendran

Data last updated:

Abimanyu Mahendran was a Director at Xyris Life Sciences Private Limited (2018–2019) and Director at Cordina Life Sciences Private Limited (2017–2018). The companies operate in Pharma and Business Services.

DIN 07828250
Primary Designation Director
Industry Pharma
First Appointment 05 Jul 2017

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xyris Life Sciences Private Limited U74999TN2018PTC120303
Director01 Jan 20182018₹47.7 Lakh (FY 2024)Active
Director05 Jul 20172017₹10.5 Lakh (FY 2019)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Xyris Life Sciences Private Limited
Cordina Life Sciences Private Limited
Premium access

Shareholding and investment profile for Abimanyu Mahendran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abimanyu Mahendran

Abimanyu Mahendran was first appointed on 05 Jul 2017 as Director at Cordina Life Sciences Private Limited. The most recent appointment on record is 01 Jan 2018 at Xyris Life Sciences Private Limited.

Abimanyu Mahendran held 2 earlier board appointments: Xyris Life Sciences Private Limited (Director, 01 Jan 2018 to 15 Mar 2019); Cordina Life Sciences Private Limited (Director, 05 Jul 2017 to 08 Jun 2018).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available